• ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation.
  Catalog No.:AP0424        Pubmed No.:21620957        PMCID:
  Details:
  Journal name:
• ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation.
  Catalog No.:BS1154        Pubmed No.:21620957        PMCID:
  Details:
  Journal name:
• ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation.
  Catalog No.:BS1544        Pubmed No.:21620957        PMCID:
  Details:
  Journal name:
• ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation.
  Catalog No.:BS1580        Pubmed No.:21620957        PMCID:
  Details:
  Journal name:
• ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation.
  Catalog No.:BS4322        Pubmed No.:21620957        PMCID:
  Details:
  Journal name:
• ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation.
  Catalog No.:BS4348        Pubmed No.:21620957        PMCID:
  Details:
  Journal name:
• ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation.
  Catalog No.:BS4706        Pubmed No.:21620957        PMCID:
  Details:
  Journal name:
• ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways
  Catalog No.:BS1030        Pubmed No.:21621522        PMCID:
  Details:
  Journal name:
• ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways
  Catalog No.:BS1089        Pubmed No.:21621522        PMCID:
  Details:
  Journal name:
• ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways
  Catalog No.:BS13278        Pubmed No.:21621522        PMCID:
  Details:
  Journal name:
• ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways
  Catalog No.:BS3711        Pubmed No.:21621522        PMCID:
  Details:
  Journal name:
• ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways
  Catalog No.:BS6428        Pubmed No.:21621522        PMCID:
  Details:
  Journal name:
• ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways
  Catalog No.:BS7004        Pubmed No.:21621522        PMCID:
  Details:
  Journal name:
• Monoclonal antibody to six transmembrane epithelial antigen of prostate-4 influences insulin sensitivity by attenuating phosphorylation of P13K (P85) and Akt: Possible mitochondrial mechanism
  Catalog No.:BS1112        Pubmed No.:21647634        PMCID:
  Details:
  Journal name:
• Monoclonal antibody to six transmembrane epithelial antigen of prostate-4 influences insulin sensitivity by attenuating phosphorylation of P13K (P85) and Akt: Possible mitochondrial mechanism
  Catalog No.:BS1810        Pubmed No.:21647634        PMCID:
  Details:
  Journal name: